Showing results (1451-1460 of 1,501) with videos related to

Sort By:
Pageof 151
Journal of Cancer Research and Clinical Oncology|November 14, 2022
Effects of gross tumor volume and radiation dose on survival and locoregional recurrence in early-stage extranodal NK/T-cell lymphoma treated with intensity-modulated radiation therapyYang-Mei Zhou, Xin Liu, Yong Yang, et al.
Technology in Cancer Research & Treatment|June 14, 2023
Voluntary Deep Inspiration Breath-Hold (VDIBH) Whole-Breast Irradiation Assisted by Optical Surface Monitoring System (OSMS) in Patients With Left-Sided Breast Cancer: A Prospective Phase II StudyJiang-Hu Zhang, Tan-Tan Li, Shi-Rui Qin, et al.
American Journal of Clinical Oncology|September 21, 2012
Clinical disparity and favorable prognoses for patients with Waldeyer ring extranodal nasal-type NK/T-cell lymphoma and diffuse large B-cell lymphomaRun-Ye Wu, Ye-Xiong Li, Wei-Hu Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|November 11, 2022
Individualized Clinical Target Volume for Irradiation of the Supraclavicular Region in Breast Cancer Based on Mapping of the Involved Ipsilateral Supraclavicular Lymph NodesHao Jing, Yu Tang, Zong-Zhan Wang, et al.
The Lancet. Oncology|February 4, 2019
Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trialShu-Lian Wang, Hui Fang, Yong-Wen Song, et al.
Cancer Letters|March 21, 2024
Disparities in mortality risk after diagnosis of hematological malignancies in 185 countries: A global data analysisJing Yang, Xin Liu, Qiu-Zi Zhong, et al.
International Journal of Radiation Oncology, Biology, Physics|April 4, 2025
Long-Term Prognostic Analysis of Chemoradiation Therapy Versus Chemotherapy after D2 Resection for High-Risk Gastric Cancer: Results From a Prospective Randomized Control StudyXia-Xi Qiao, Huan-Gang Jiang, Yuan Tang, et al.
Journal of Orthopaedic Translation|October 21, 2024
The CD163/TWEAK/Fn14 axis: A potential therapeutic target for alleviating inflammatory bone lossJi-Kun Qian, Yuan Ma, Xuan Huang, et al.
Cancer Medicine|January 5, 2024
Prediction of 5-year overall survival of diffuse large B-cell lymphoma on the pola-R-CHP regimen based on 2-year event-free survival and progression-free survivalWan-Ru Zhang, Xin Liu, Qiu-Zi Zhong, et al.
Frontiers in Oncology|January 6, 2023
Risk factors to identify the indication for regional nodal irradiation in T1-2N1M0 breast cancer: A joint analysis of 4,243 real-world cases from two institutionsGuang-Yi Sun, Ge Wen, Yu-Jing Zhang, et al.
Pageof 151